gopubmed logo
find other proteinsAll proteins
GoPubMed Proteins lists recent and important papers and reviews for proteins. Page last changed on 19 Aug 2016.

Keratin 19

cytokeratin 19, CK19, K19, keratin 19
The protein encoded by this gene is a member of the keratin family. The keratins are intermediate filament proteins responsible for the structural integrity of epithelial cells and are subdivided into cytokeratins and hair keratins. The type I cytokeratins consist of acidic proteins which are arranged in pairs of heterotypic keratin chains. Unlike its related family members, this smallest known acidic cytokeratin is not paired with a basic cytokeratin in epithelial cells. It is specifically expressed in the periderm, the transiently superficial layer that envelopes the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21. [provided by RefSeq, Jul 2008] (from NCBI)
Top mentioned proteins: cytokeratin, CAN, HAD, CK7, vimentin
Papers using cytokeratin 19 antibodies
Current concepts on oxidative/carbonyl stress, inflammation and epigenetics in pathogenesis of chronic obstructive pulmonary disease.
Kodavanti Urmila P. et al., In Environmental Health Perspectives, 2010
... and cytokeratin 14 (sc-53253) using antibodies from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and cytokeratin 19 (CRC946) from Cell Marque (Rocklin, CA, USA).
Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients
Richardson Andrea L et al., In Breast Cancer Research : BCR, 2008
antibody, BD Biosciences, San Jose, CA, USA), CK18 (DC10 antibody, Dako) and CK19 (RCK108 antibody, Dako) as well as for ...
The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells
Michalopoulos George K et al., In Comparative Hepatology, 2006
... Primary antibodies used are: CK19 (Dako Corp; 1:100), HNF4α (Santa ...
P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing Axin from β-catenin
Oshima Masanobu et al., In The EMBO Journal, 2005
... K19-C2mE transgenic mice has been described ...
Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer
Schultze Frank C. et al., In Histochemistry and Cell Biology, 2004
... Anti-CK-19 mouse monoclonalIHC1:50Leica Biosys ...
more suppliers
Papers on cytokeratin 19
Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
Mahajan et al., New Delhi, India. In Tumour Biol, Feb 2016
The study included 50 patients of OSCC to evaluate levels of Cyfra 21-1 in serum and saliva by electrochemiluminescent immunoassay (ECLIA) and CK19 messenger RNA (mRNA) expression in tissue by florescent quantitative real-time reverse transcriptase polymerase chain reaction (RT-PCR) along with healthy individuals as control.
Thymic Carcinoma with Cartilage Formation in a Dog.
Uchida et al., Tokyo, Japan. In J Comp Pathol, Feb 2016
Immunohistochemically, the tumour cells, as well as the normal canine thymic epithelial cells, were positive for pan-cytokeratin (CK), CK5/6, CK19, p63 and bone morphogenetic protein (BMP) 6. Foci of cartilage tissue were formed in association with the neoplastic epithelial tissue.
Primary, large extra-axial chordoma in proximal tibia: a rare case report with literature review and diagnostic implications.
Rekhi, Mumbai, India. In Apmis, Dec 2015
By immunohistochemistry, tumour cells were diffusely positive for pan cytokeratin (AE1/AE3), epithelial membrane antigen (EMA), CK19, S100P, meso (HBME1) and Brachyury/T.
[Effect of Flos Daturae Alkaloids on TGF-beta1-induced Epithelial-Mesenchymal Transition of Human Pulmonary Adenocarcinoma A549 Cells].
Lv et al., In Zhongguo Zhong Xi Yi Jie He Za Zhi, Nov 2015
Western blot showed that, when compared with the blank control group, the expression of CK-19 was down-regulated, but the expression of alpha-SMA was up-regulated in the TGF-beta1 group (P < 0.01).
[Huikangling Tablet Intervened Peripheral Blood Micrometastasis of Differentiated Thyroid Carcinoma].
Deng et al., In Zhongguo Zhong Xi Yi Jie He Za Zhi, Nov 2015
Peripheral micrometastatic cytokeratin 19 (CK19) and polymorphic epithelial mucin1 (MUC1) were detected by FCM at week 4 and 12.
Thyroid-like follicular carcinoma of the kidney: one case report and review of the literature.
Nodit et al., Pittsburgh, United States. In Am J Clin Pathol, Nov 2015
The tumor cells strongly expressed CK7, PAX-8, PAX-2, vimentin, EMA, and CK19 immunostains.
The expression of CK-19 gene in circulating tumor cells of blood samples of metastatic breast cancer women.
Panjehpour et al., Eşfahān, Iran. In Res Pharm Sci, Nov 2015
In this study, the expression of CK-19 gene in blood samples of metastatic breast cancer women was investigated and compared to control group.
Cutaneous metastases from gastric adenocarcinoma 15 years after curative gastrectomy.
Sang et al., Nanjing, China. In An Bras Dermatol, May 2015
They were stained positive for villin, CDX-2, CKpan (AE1/ AE3), CEA, CK8/18, CK19, CK7, EMA, Ki-67 (50%), and negative for S-100, CK20, CD34, GCDFP-15 and TTF-1.
Quantitative assessment of the cell surface proteome to identify novel therapeutic targets in cholangiocarcinoma.
Afford et al., Birmingham, United Kingdom. In Lancet, Mar 2015
They included proteins used clinically for staging disease (cytokeratin 19 [CK19]), identifying cancer stem cells (epithelial cell adhesion molecule [EpCAM], neural cell adhesion molecule [NCAM], epithelial growth factor receptor [EGFR]), and indicating potential for differentiation (Frozzled receptor, Notch pathway).
Randomized phase II study of carboplatin and paclitaxel with either linifanib or placebo for advanced nonsquamous non-small-cell lung cancer.
Gorbunova et al., Atlanta, United States. In J Clin Oncol, Mar 2015
Baseline plasma carcinoembryonic antigen/cytokeratin 19 fragments biomarker signature was associated with PFS improvement and a trend toward OS improvement with linifanib 12.5 mg.
Pathology: Classification and Immunoprofile.
Perren et al., Bern, Switzerland. In Front Horm Res, 2014
Many immunohistochemical markers have been shown to correlate with prognosis but are not used in clinical practice, for example cytokeratin 19 and KIT expression in pancreatic NETs.
Urinary biomarkers for the non-invasive diagnosis of endometriosis.
Hull et al., Auckland, New Zealand. In Cochrane Database Syst Rev, 2014
Five studies evaluated the diagnostic performance of four urinary biomarkers for endometriosis, including three biomarkers distinguishing women with and without endometriosis (enolase 1 (NNE); vitamin D binding protein (VDBP); and urinary peptide profiling); and one biomarker (cytokeratin 19 (CK 19)) showing no significant difference between the two groups.
Structural and functional evaluation of branched myofibers lacking intermediate filaments.
Lovering et al., Baltimore, United States. In Am J Physiol Cell Physiol, 2012
Branched desmin-deficient (DKO) myofibers show significantly faster rates of calcium ion (Ca2+) clearance, with milder branching phenotype observed in DKO muscle suggesting that absence of keratin-19 corrects the defect created by absence of desmin alone.
Expression of basal cell keratin 15 and keratin 19 in oral squamous neoplasms represents diverse pathophysiologies.
Yamaguchi et al., Tokyo, Japan. In Histol Histopathol, 2012
K19 expressed variably in both oral squamous cell carcinoma and squamous intraepithelial neoplasm
Importance of assessing CK19 immunostaining in core biopsies in patients subjected to sentinel node study by OSNA.
Matias-Guiu et al., Lleida, Spain. In Virchows Arch, 2012
lack of expression of CK19 is infrequent in breast cancers, they do occur not only in tumors with a triplenegative or basal-like phenotype but also in breast cancers with a luminal phenotype
Expression of cytokeratin 19, HBME-1 and galectin-3 in neoplastic and nonneoplastic thyroid lesions.
Kabukçuoglu et al., Turkey. In Pol J Pathol, 2012
105 cases of thyroid lesions were evaluated to assess the role of HBME-1, cytokeratin-19 (CK-19), galectin-3 in distinguishing benign from malignant thyroid lesions.
Usefulness of cytokeratin-19, galectin-3, and Hector Battifora mesothelial-1 in the diagnosis of benign and malignant thyroid nodules.
Zhang et al., China. In Clin Lab, 2011
combined use of CK19, Gal-3, and HBME-1 is of practical value in the diagnosis and differential diagnosis of benign and malignant thyroid nodules
Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.
Gordon et al., Baltimore, United States. In J Clin Oncol, 2011
and cytokeratin 19 fragment antigen 21-1 (P = .01)
Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer.
Mavroudis et al., Irákleion, Greece. In J Clin Oncol, 2009
PURPOSE: To evaluate the prognostic significance of cytokeratin-19 (CK-19) mRNA-positive circulating tumor cells (CTCs) in peripheral blood of women with early-stage breast cancer after the completion of adjuvant chemotherapy.
Novel intraoperative molecular test for sentinel lymph node metastases in patients with early-stage breast cancer.
Giuliano et al., Pittsburgh, United States. In J Clin Oncol, 2008
METHODS: A beta trial (n = 304) to determine the threshold levels of mammaglobin and cytokeratin 19 correlating with metastasis greater than 0.2 mm and a validation trial (n = 416) to validate the threshold cutoffs were conducted.
More papers using cytokeratin 19 antibodies
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
Borthwick Lee A. et al., In The American Journal of Pathology, 2004
... E-cadherin (610181; Becton, Dickinson and Company, Oxford, UK), fibronectin (F3648; Sigma-Aldrich, Poole, UK), cytokeratin-19 (sc-6278; Santa Cruz Biotechnology, Inc., Santa Cruz, CA), ...
Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy
Alzohaili Opada et al., In Diagnostic Pathology, 2004
... CK19RCK1081:100HIER EDTA BufferDako Corp ...
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
Saitoh M et al., In Oncogene, 2003
... Rabbit monoclonal anti-keratin 19 and polyclonal δEF1 antibodies were purchased from Epitomics (Burlingame, CA, USA) and ...
Connective tissue growth factor and renal diseases: some answers, more questions
Zhang Zhi et al., In Respiratory Research, 2003
... splice form (Fn-EDA) and anti-human cytokeratin-19 were purchased from Abcam Ltd (Cambridge, UK) ...
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
Mukhopadhyay Asok et al., In The Indian Journal of Medical Research, 2002
... anti-megalin (a kind gift of Mr Dan Biemesderfer, Yale University, USA), anti-E-cadherin (Abcam plc., UK), anti-CK-19 (Santa Cruz Biotechnology Inc., USA), and mouse ...
Cancer genetics
Strauss Brian L et al., In Breast Cancer Research, 2000
... AE1/AE3 (clones AE1/AE3; Chemicon, Temecula, CA, USA), to cytokeratin 8 (clone TS1; Vector Laboratories), and to cytokeratin 19 (clone b170; Vector Laboratories) in order to assess ...
Histochemical heterogeneity of human mast cells: disease-related differences in mast cell subsets recovered by bronchoalveolar lavage
Onitsuka Toshio et al., In World Journal of Surgical Oncology, 1989
... The specific monoclonal antibody against cytokeratin 19 (Santa Cruz Biotechnology, California, U.S.A.) was used ...
Glutahione replenishment capacity is lower in isolated perivenous than in periportal hepatocytes
Afford Simon C. et al., In Febs Letters, 1987
... serum (Sigma) before the addition of mouse anti-human mAb (IgG Isotype-matched control (Invitrogen) CD31 (Dako), cytokeratin 19 (Dako), cytokeratin 18 (Invitrogen) for ...
share on facebooktweetadd +1mail to friends